Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Anandamide
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sugiura T and Waku K | Cannabinoid receptors and their endogenous ligands. | 2002 | J. Biochem. | pmid:12097154 |
Ross RA et al. | Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. | 2002 | J. Pharmacol. Exp. Ther. | pmid:12023517 |
Smart D et al. | 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. | 2002 | Br. J. Pharmacol. | pmid:12023948 |
Farquhar-Smith WP et al. | Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. | 2002 | Pain | pmid:12031775 |
Porter AC et al. | Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. | 2002 | J. Pharmacol. Exp. Ther. | pmid:12023533 |
Kirkham TC et al. | Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. | 2002 | Br. J. Pharmacol. | pmid:12055133 |
Vinklerová J et al. | Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. | 2002 | J. Psychopharmacol. (Oxford) | pmid:12095072 |
Williams CM and Kirkham TC | Observational analysis of feeding induced by Delta9-THC and anandamide. | 2002 | Physiol. Behav. | pmid:12044596 |
Kreitzer AC and Regehr WG | Retrograde signaling by endocannabinoids. | 2002 | Curr. Opin. Neurobiol. | pmid:12049940 |
Maccarrone M et al. | Endocannabinoid degradation, endotoxic shock and inflammation. | 2002 | Curr Drug Targets Inflamm Allergy | pmid:14561206 |
Wallace MJ et al. | Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. | 2002 | Eur. J. Pharmacol. | pmid:12359270 |
Darmani NA | The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. | 2002 | J. Pharmacol. Exp. Ther. | pmid:11752094 |
Del Arco I et al. | Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. | 2002 | Eur. J. Pharmacol. | pmid:12409011 |
Gómez R et al. | A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. | 2002 | J. Neurosci. | pmid:12417686 |
González S et al. | Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. | 2002 | Brain Res. | pmid:12393235 |
Maccarrone M et al. | Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. | 2002 | Blood | pmid:12393387 |
Mascolo N et al. | The endocannabinoid system and the molecular basis of paralytic ileus in mice. | 2002 | FASEB J. | pmid:12397089 |
Mukhopadhyay S et al. | Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12003810 |
Bisogno T et al. | Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. | 2002 | Curr. Pharm. Des. | pmid:11945157 |
Palmer SL et al. | Cannabinergic ligands. | 2002 | Chem. Phys. Lipids | pmid:12505686 |
Razdan RK and Mahadevan A | Recent advances in the synthesis of endocannabinoid related ligands. | 2002 | Chem. Phys. Lipids | pmid:12505687 |
Kunos G et al. | The quest for a vascular endothelial cannabinoid receptor. | 2002 | Chem. Phys. Lipids | pmid:12505689 |
Wiley JL and Martin BR | Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. | 2002 | Chem. Phys. Lipids | pmid:12505690 |
Schmid HH et al. | Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. | 2002 | Chem. Phys. Lipids | pmid:12505695 |
Cravatt BF and Lichtman AH | The enzymatic inactivation of the fatty acid amide class of signaling lipids. | 2002 | Chem. Phys. Lipids | pmid:12505696 |
Paria BC et al. | Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. | 2002 | Chem. Phys. Lipids | pmid:12505701 |
Kozak KR et al. | Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. | 2002 | J. Biol. Chem. | pmid:12244105 |
Burstein SH et al. | Regulation of anandamide tissue levels by N-arachidonylglycine. | 2002 | Biochem. Pharmacol. | pmid:12234618 |
Luo C et al. | Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of capsaicin. | 2002 | Neurosci. Lett. | pmid:11872246 |
Wenger T et al. | The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. | 2002 | Life Sci. | pmid:11883716 |
Molina-Holgado F et al. | Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. | 2002 | J. Neurosci. Res. | pmid:11891798 |
Ford WR et al. | Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. | 2002 | Br. J. Pharmacol. | pmid:11877326 |
Harris D et al. | Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. | 2002 | J. Physiol. (Lond.) | pmid:11897858 |
Lin YS and Lee LY | Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors. | 2002 | J. Physiol. (Lond.) | pmid:11897863 |
van der Stelt M et al. | Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. | 2002 | J. Med. Chem. | pmid:12166944 |
Mechoulam R et al. | Cannabinoids and brain injury: therapeutic implications. | 2002 | Trends Mol Med | pmid:11815270 |
Laine K et al. | Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides. | 2002 | Invest. Ophthalmol. Vis. Sci. | pmid:11818382 |
Maccarrone M et al. | Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. | 2002 | Mol. Hum. Reprod. | pmid:11818522 |
Someya A et al. | Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells. | 2002 | Eur. J. Pharmacol. | pmid:12206851 |
Di Marzo V et al. | A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. | 2002 | J. Pharmacol. Exp. Ther. | pmid:11861807 |
Barnett-Norris J et al. | Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. | 2002 | J. Med. Chem. | pmid:12166938 |
Habayeb OM et al. | Endogenous cannabinoids: metabolism and their role in reproduction. | 2002 | Life Sci. | pmid:12148689 |
Szallasi A | Vanilloid (capsaicin) receptors in health and disease. | 2002 | Am. J. Clin. Pathol. | pmid:12109845 |
Dinh TP et al. | Brain monoglyceride lipase participating in endocannabinoid inactivation. | 2002 | Proc. Natl. Acad. Sci. U.S.A. | pmid:12136125 |
Liu WM et al. | Effects of anandamide on embryo implantation in the mouse. | 2002 | Life Sci. | pmid:12137909 |
Di Marzo V et al. | Endovanilloid signaling in pain. | 2002 | Curr. Opin. Neurobiol. | pmid:12139983 |
Matias I et al. | Presence and regulation of the endocannabinoid system in human dendritic cells. | 2002 | Eur. J. Biochem. | pmid:12153574 |
Schäbitz WR et al. | Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. | 2002 | Stroke | pmid:12154273 |
Chemin J et al. | Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. | 2002 | J. Neurosci. | pmid:12177183 |
Gubellini P et al. | Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | 2002 | J. Neurosci. | pmid:12177188 |